Management
Senior Management
E. Kevin Hrusovsky
President and Chief Executive Officer
David M. Manyak, Ph.D.
Executive Vice President, Drug Discovery Services
Peter F. McAree
Senior Vice President and Chief Financial Officer
Bruce J. Bal
Senior Vice President, Operations
Stephen E. Creager
Senior Vice President, General Counsel and Secretary
William C. Kruka
Senior Vice President, Corporate Development
Enrique Bernal
Senior Vice President, In Vitro Business Development
Paula J. Cassidy
Senior Vice President, Human Resources
Bradley W. Rice, Ph.D.
Senior Vice President, Systems and R&D
Mark T. Roskey, Ph.D.
Senior Vice President, Applied Biology R&D
Board of Directors
Bob Bishop
Chairman of the Board
David Milligan, Ph.D
Vice Chairman of the Board
Former Chief Scientific Officer, Abbott Laboratories
Van Billet
Chief Financial Officer, The Berwind Company LLC
Robert C. Bishop, Ph.D
Chairman and Chief Executive Officer, AutoImmune
David Carter
President, DaCart, Former CEO and Chairman, Xenogen
Allan L. Comstock
Former Vice President and Controller of Atlantic Richfield Company (ARCO)
Kevin Hrusovsky
President and Chief Executive Officer, Caliper Life Sciences
Kathryn Tunstall
Former President and Chief Executive Officer, Conceptus
Biographies
E. Kevin HrusovskyPresident and Chief Executive Officer
Mr. Hrusovsky was appointed President and CEO of Caliper Life Sciences immediately following the acquisition of Zymark Corporation by Caliper in July 2003. Prior to the acquisition, Mr. Hrusovsky served as President and CEO for Zymark starting in late 1996. Mr. Hrusovsky successfully transformed Zymark from a custom robotics company into a formidable Life Sciences "Tools" company through acquisitions, R&D investment and recruitment of top industry talent. Under Mr. Hrusovsky's leadership, Zymark developed a strong global channel into the biotechnology and pharmaceutical industry, with subsequent expansion into the genomics and proteomics market. Mr. Hrusovsky has senior management relationships throughout the pharmaceutical and biotechnology industries, and has been instrumental in developing strategic collaborations with many leading pharmaceutical, biotechnology and life sciences tools and technology companies.
Before joining Zymark, Mr. Hrusovsky was president of the Pharmaceutical Division at FMC and ran the Teflon and other specialty businesses at Dupont. His entire career has been associated with managing transformative innovation into sustainable profitable enterprises. He is on the Global Research Council for Children’s Hospital, Boston and is a member of the Advisory Committee for the Center for Biomedical Engineering at Brown University. He received an Honorary Doctorate degree from Framingham State University for contributions to life sciences. Mr. Hrusovsky holds a BSME from Ohio State and M.B.A. from Ohio University. He and his family are authentic Buckeyes!
Top of page
David M. Manyak, Ph.D.Executive Vice President, Drug Discovery Services
Dr. Manyak has nearly 20 years of experience in research, financial analysis, and management of biotechnology companies. Dr. Manyak was a biotechnology industry consultant and was co-founder and former Director of GeneMedicine Inc., a gene therapy company that had its initial public offering in 1994 and has since merged to form Valentis Corp. He was among the first biotechnology securities analysts on Wall Street, as V.P., Sr. Biotechnology Industr y Analyst for Merrill Lynch & Co. (1985-90) and held a similar position with Value Line Inc. (1983-85). Dr. Manyak holds a Ph.D. in Zoology/Biochemistry from Duke University.
Top of page
Peter F. McAreeSenior Vice President and Chief Financial Officer
Mr. McAree previously served as Vice President, Finance and was Chief Financial Officer of Zymark Corporation from 2000 until its 2003 merger with Caliper. He has 20 years of combined financial management and public accounting experience and served as CFO at a number of public and private companies in the software and retail industries. Mr. McAree is a Certified Public Accountant in the Commonwealth of Massachusetts and hold a Bachelor of Science in Accountancy from Bentley College.
Top of page
Bruce J. BalSenior Vice President, Operations
Mr. Bal was appointed to the position of Sr. Vice President, Operations following the combination of Caliper Technologies with Zymark Corporation. Mr.Bal joined Zymark in 1997 as Vice President of R&D and Operations. He previously worked at FMC Corporation in the Biotechnology Division as Director of Operations. He has also held a wide range of management positions in his 13 years at Dupont and was general manager of USPCI in Utah. Mr. Bal received a B.S. in Chemical Engineering from the University of Wisconsin in 1981 and an MBA from Loyola University, Louisiana in 1986.
Top of page
Stephen E. CreagerSenior Vice President, General Counsel and Secretary
Mr. Creager joined Caliper in October 2002 as Associate General Counsel and was appointed Senior Vice President, General Counsel and Secretary in June 2003. Prior to joining Caliper, Mr. Creager was Vice President of Business Development for Tyco Electronics, an operating unit of Tyco International involved in the development and manufacture of electronic components, with approximately $12 billion of annual revenue. In this role, he provided the legal support for the business development initiatives of Tyco Electronics, including the acquisition of over 40 businesses. Prior to taking on these business development responsibilities at Tyco Electronics, Mr. Creager served as the General Counsel of Tyco Electronics. Prior to that, Mr. Creager served as Associate General Counsel of Raychem Corporation from November 1993 until August 1999, when Raychem was acquired by Tyco Electronics. Prior to that, Mr. Creager was in private legal practice for nine years. Mr. Creager received a Bachelor of Arts degree from The Evergreen State College, and a Masters of Philosophy degree in economics and a J.D. degree, both from Yale University.
Top of page
William C. KrukaSenior Vice President, Corporate Development
Mr. Kruka joined Caliper in 2002 as Vice President, Business Development. Prior to joining Caliper, Mr. Kruka was Senior Manager of Business Development with Applied Biosystems Group, an Applera Corporation business. In this role, he led the business development initiatives for proteomics, including related mass spectrometry; sample preparation; chromatography and microfluidic technologies. These initiatives included developing strategy, formulating deal structures and negotiating collaborations, licensing deals and divestitures. He also chaired an internal business development council that addressed strategic and operational matters from a cross-functional business and technology perspective. Prior to Applied Biosystems, Mr. Kruka held a number of corporate business development, sales and marketing positions with Perkin-Elmer.
Top of page
Enrique BernalSenior Vice President, In Vitro Business Development
Mr. Bernal was appointed to the position of Senior Vice President, Automation Business Development following the combination of Caliper Technologies with Zymark Corporation. Mr. Bernal joined Zymark in February 1999, prior to which he worked at Galileo Corporation of Sturbridge, Massachusetts, where he was responsible for all engineering functions and product development. Previously, he had spent 29 years at Honeywell Inc. He received a B.S. in Physics from the College of St. Thomas, and a Masters in Physics from the University of Minnesota. Mr. Bernal is the co-inventor of eight U.S. patents and has published 36 technical papers.
Top of page
Paula J. CassidySenior Vice President, Human Resources
Ms. Cassidy joined Caliper Life Sciences in November 2005 as Vice President, Human Resources. Prior to joining Caliper, Ms. Cassidy was Vice President, Human Resources at Virtusa, Corp., a global provider of software development and related IT services. In that position, Ms. Cassidy was responsible for all aspects of the human resources function and she established a cohesive and unified global HR practice. Prior to joining Virtusa Corp in 2003, Ms. Cassidy was with Innoveda, Inc., a publicly traded provider of software and services for the electronic design automation industry. Innoveda had facilities all over the world including the US, Europe, Israel and Asia. Prior to Innoveda, Ms. Cassidy was Vice President, Human Resources for a wholly-owned subsidiary of Synopsys, Inc.. She started her career in Human Resources at Viewlogic Systems, Inc. and held various management positions while at Viewlogic. Ms. Cassidy holds a bachelors degree with honors from St. Anselm College.
Top of page
Bradley W. Rice, Ph.D.Senior Vice President, Systems and R&D
Dr. Rice has served as the Chief Technical Officer and Vice President of Xenogen since January 2005. From 1999 through 2004, he served as the Sr Director of Imaging R&D and played a key role in developing the suite of IVIS® Imaging Systems. Prior to joining Xenogen, Dr. Rice worked for 15 years as a scientist at Lawrence Livermore National Laboratory developing optical diagnostic instrumentation in the magnetic fusion energy program. Dr. Rice received his B.A. in Physics from Colorado College, M.S. in Electrical Engineering from the University of Wisconsin-Madison, and his Ph.D. in Applied Science from the University of California-Davis. He is author or co-author of over 50 refereed journal publications and Co-inventor of nine issued patents related to biophotonic imaging.
Top of page
Mark T. Roskey, Ph.D.Senior Vice President, Applied Biology R&D
Dr. Roskey was appointed to the position of Vice President, Reagents and Applied Biology, in 2005. From 2001 until 2005 he held the position of Vice President, Worldwide Marketing at Caliper and at Zymark prior to its acquisition by Caliper. Prior to that, Dr. Roskey worked at Applied Biosystems where he served as Director of Marketing. He has more than 13 years of experience in product research, development and strategic marketing with complex biological solutions and automated instrument systems. Dr. Roskey completed a postdoctoral fellowship in Molecular Immunobiology at the Harvard Medical School, and holds a Ph.D. in Microbiology from the University of Notre Dame.
Top of page
